Coupang Stock Falls 18% as Analysts Hold $25 Targets
Coupang stock has shed 18% over nine consecutive losing sessions, landing at approximately $15.25 against an average analyst price target of $25.83. With two EPS misses in three recent quarters and a
Coupang Stock Falls 18% as Analysts Hold $25 Targets
NEW YORK, July 29 —
Nine consecutive losing sessions have erased 18% of Coupang's market value, leaving shares at approximately $15.25 — a price more than $10 below the average analyst target of $25.83. The slide extended with an additional 3.1% decline in the most recent session. Wall Street, as a group, has not moved its recommendations.
- Trailing twelve-month revenue of $35.13 billion, growing 7.5% year-over-year
- Free cash flow of $242 million on a trailing basis, against a market cap of approximately $27.37 billion
Nine Days of No
A nine-session losing streak that erases 18% is not routine retracement. Per Trefis, the move has been sustained and consistent — the kind of price action that tends to reflect institutional repositioning rather than retail noise. GuruFocus places intrinsic value at $28 per share, implying substantial upside from $15.25. The market, plainly, is running a different model, and the market moves in real time while valuation frameworks do not.
The Analyst Standoff
With an average price target of $25.83 and a current price around $15.25, implied upside exceeds 69%. Per Yahoo Finance, analysts are broadly still recommending the stock despite the recent slide. The question that hangs over that consensus: is it conviction, or is it inertia?
The optimistic reading is that the selloff is sentiment-driven, fundamentals remain intact, and the gap represents genuine dislocation. The skeptical reading is that sell-side targets are famously sticky, and the market's sustained selling reflects something the models have not fully digested. A $10-plus gap between consensus and market price is large enough that one of those parties is significantly wrong — the evidence is too balanced to call which one.
A 52x Multiple on Erratic Execution
A forward P/E of 52.7x is a growth premium — what the market assigns when it expects rapid, durable earnings expansion. Three quarters ago, the company posted $0.05 against a $0.04 estimate, a clean beat. Four quarters ago, EPS of $0.02 missed a $0.05 consensus by a wide margin.
Two misses and one beat across three recent quarters is not the earnings trajectory that supports a 52x multiple. Paying a growth premium for inconsistent execution requires confidence that the path forward breaks decisively in the right direction. That confidence is under direct stress at $15.25.
The Structural Counterargument
Strip away the earnings volatility and the underlying business looks different. Trailing revenue of $35.13 billion growing at 7.5% is real commercial scale, not a story stock. Gross margin of 28.8% is defensible for an e-commerce operator running its own logistics infrastructure. Free cash flow of $242 million on a trailing basis demonstrates the business can generate cash even when GAAP earnings are negative — a distinction that matters, since growth-stage e-commerce companies routinely diverge on GAAP EPS versus operating cash generation.
A market cap of approximately $27.37 billion against $35.13 billion in annual revenue implies a price-to-sales ratio just under 0.8x. The revenue base is not the problem. The question is whether the earnings trajectory will eventually justify what remains, today, an elevated forward multiple.
What Breaks the Standoff
A neutral stance is the honest position. Revenue growth and free cash flow point toward a functional business with staying power. Inconsistent earnings execution, a 52.7x forward multiple on negative trailing EPS, and a nine-session losing streak point toward near-term risk. Neither argument has a decisive edge.
The next quarterly earnings report is the natural checkpoint. A clean beat with improving margin trajectory would give the bull case the evidence it currently lacks. Another miss at this multiple would make the valuation difficult to defend regardless of the revenue line. Analyst model updates, when they arrive, will narrow the $10-plus gap between consensus and market price — the open question is which direction that adjustment runs.
Run the free Coupang, Inc. deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Why is Coupang stock falling?
Coupang stock has declined 18% over nine consecutive losing sessions, per Trefis, with an additional 3.1% decline in the most recent session. The sustained move reflects deteriorating near-term sentiment, though the company reported $35.13 billion in trailing revenue growing 7.5% and $242 million in free cash flow.
What is Coupang's analyst price target?
The average analyst price target for Coupang is $25.83, against a current share price of approximately $15.25. That gap of more than $10 implies over 69% upside from current levels, and analysts have broadly maintained their recommendations through the recent slide, per Yahoo Finance.
Did Coupang miss earnings estimates recently?
Coupang posted EPS of -$0.01 in its most recently reported quarter, missing the consensus estimate of $0.045. The company has missed EPS estimates in two of the three most recently reported quarters, a track record that adds friction to the case for a forward P/E of 52.7x.
Is Coupang stock a buy right now?
Analysts are broadly recommending the stock with a $25.83 consensus target, but the forward P/E of 52.7x on negative trailing EPS and two recent earnings misses make it a difficult call. Revenue of $35.13 billion growing 7.5% and $242 million in trailing free cash flow provide structural support, while the next earnings report is the key near-term inflection point.
What is Coupang's revenue and market cap?
Coupang reported trailing twelve-month revenue of $35.13 billion, growing 7.5% year-over-year. At the current share price of approximately $15.25, the company's market cap is roughly $27.37 billion, implying a price-to-sales ratio just under 0.8x.
Coupang (CPNG) shed 18% over nine consecutive losing sessions according to reports from Trefis, a sustained slide that leaves the stock at approximately $15.25 — sharply below the average analyst price target of $25.83. The decline is continuing into the current session, yet analysts have not broadly pulled their buy recommendations.